Bokus

Moshe Elkabets – författare

Visar alla böcker från författaren Moshe Elkabets. Handla med fri frakt och snabb leverans.

3 produkter

  1. Yosef Yarden, Moshe Elkabets - Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways, Inbunden. Tillgänglighet: Lägg i varukorg

    Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

    Av Yosef Yarden, Moshe Elkabets

    Inbunden, 2018

    1688 kr

    Lägg i varukorg

    This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play …

  2. Moshe Elkabets, Yosef Yarden - Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways, E-bok. Tillgänglighet: Lägg i varukorg

    Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

    Av Moshe Elkabets, Yosef Yarden

    E-bok, 2018

    2127 kr

    Lägg i varukorg

    This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play …

  3. Yosef Yarden, Moshe Elkabets - Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways, Häftad. Tillgänglighet: Tillfälligt slut

    Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

    Av Yosef Yarden, Moshe Elkabets

    Häftad, 2019

    2149 kr

    Tillfälligt slut

    This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play …